These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6580064)

  • 1. Double minute chromatin bodies and other chromosome alterations in human myeloid HL-60 leukemia cells susceptible or resistant to induction of differentiation by phorbol-12-myristate-13-acetate.
    Au WW; Callaham MF; Workman ML; Huberman E
    Cancer Res; 1983 Dec; 43(12 Pt 1):5873-8. PubMed ID: 6580064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific protein phosphorylation in human promyelocytic HL-60 leukemia cells susceptible or resistant to induction of cell differentiation by phorbol-12-myristate-13-acetate.
    Anderson NL; Gemmell MA; Coussens PM; Murao S; Huberman E
    Cancer Res; 1985 Oct; 45(10):4955-62. PubMed ID: 3861240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane lipid dynamics in human promyelocytic leukemia cells sensitive and resistant to 12-O-tetradecanoylphorbol-13-acetate induction of differentiation.
    Fisher PB; Schachter D; Abbott RE; Callaham MF; Huberman E
    Cancer Res; 1984 Dec; 44(12 Pt 1):5550-4. PubMed ID: 6594192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
    Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
    Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionally deficient differentiation of HL-60 promyelocytic leukemia cells induced by phorbol myristate acetate.
    Newburger PE; Baker RD; Hansen SL; Duncan RA; Greenberger JS
    Cancer Res; 1981 May; 41(5):1861-5. PubMed ID: 6260353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation.
    Cossu G; Kuo AL; Pessano S; Warren L; Cooper RA
    Cancer Res; 1982 Feb; 42(2):484-9. PubMed ID: 6948606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of differentiation of human promyelocytic leukemia (HL-60) cells by teleocidin and phorbol-12-myristate-13-acetate.
    Huberman E; Braslawsky GR; Callaham M; Fugiki H
    Carcinogenesis; 1982; 3(1):111-4. PubMed ID: 6802509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
    Mascioli DW; Estensen RD
    Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amplification of genome regions in the somatic cells of mammals resistant to colchicine. III. Localization of the amplified genes in minute chromatin bodies].
    Kopnin BP; Gudkov AV
    Genetika; 1982 Oct; 18(10):1683-92. PubMed ID: 6293922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability of HL-60 cells induced by phorbol myristate acetate to produce macrophage-associated glycosaminoglycans.
    Luikart SD
    Exp Hematol; 1986 Aug; 14(7):672-5. PubMed ID: 3460812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro and in vivo differentiation of myeloblastic leukemia of the RFM/Un mouse.
    Weinberg JB; Misukonis MA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5594-8. PubMed ID: 6594193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C activities with different characteristics, including substrate specificity, from two human HL-60 leukemia cell variants.
    Homma Y; Gemmell MA; Huberman E
    Cancer Res; 1988 May; 48(10):2744-8. PubMed ID: 3162823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosaminoglycan synthesis during differentiation of HL60/HGPRT-leukemia cells induced by dimethyl sulfoxide and 12-O-tetradecanoylphorbol-13-acetate.
    Luikart SD; Maniglia CA; Sartorelli AC
    Cancer Res; 1984 Jul; 44(7):2907-12. PubMed ID: 6586291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation.
    Koeffler HP; Bar-Eli M; Territo MC
    Cancer Res; 1981 Mar; 41(3):919-26. PubMed ID: 6936077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
    Taipale J; Matikainen S; Hurme M; Keski-Oja J
    Cell Growth Differ; 1994 Dec; 5(12):1309-19. PubMed ID: 7696179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.
    Beran M; Andersson BS
    Cancer Res; 1987 Apr; 47(7):1897-904. PubMed ID: 3469023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations.
    Slovak ML; Hoeltge GA; Trent JM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6646-52. PubMed ID: 3677098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.